Things appear to be looking up for ChromaDex Corporation (CDXC)

ChromaDex Corporation (NASDAQ: CDXC) is 10.67% higher on its value in year-to-date trading and has touched a low of $2.50 and a high of $5.80 in the current 52-week trading range. The CDXC stock was last observed hovering at around $4.77 in the recent trading session, with the current gains setting it 0.22%.

The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.


At last check, trading at $4.99, the stock is 12.06% and 5.90% above its SMA20 and SMA50 respectively. However, with a current trading volume of 0.55 million and changing 4.61% at the moment leaves the stock 25.53% off its SMA200. CDXC registered 6.24% gain for a year compared to 6-month gain of 5.53%. The firm has a 50-day simple moving average (SMA 50) of $4.55 and a 200-day simple moving average (SMA200) of $4.19.

The stock witnessed a 3.25% loss in the last 1 month and extending the period to 3 months gives it a 41.54%, and is 3.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.75% over the week and 5.22% over the month.

ChromaDex Corporation (CDXC) has around 110 employees, a market worth around $292.64M and $50.60M in sales. Profit margin for the company is -58.70%. Distance from 52-week low is 99.60% and -13.97% from its 52-week high.

ChromaDex Corporation (CDXC) Analyst Forecasts

ChromaDex Corporation is expected to release its quarterly report on 08/06/2020 and quarterly earnings per share for the current quarter are estimated at -$0.1 with sales reaching $13.87M over the same period.The EPS is expected to grow by 7.00% this year, but quarterly earnings will post 30.80% year-over-year.

ChromaDex Corporation (CDXC) Top Institutional Holders

87 institutions hold shares in ChromaDex Corporation (CDXC), with 25.49M shares held by insiders accounting for 41.59% while institutional investors hold 35.70% of the company’s shares. The shares outstanding are 59.78M, and float is at 36.62M with Short Float at 6.06%. Institutions hold 20.86% of the Float.

ChromaDex Corporation (CDXC) Insider Activity

A total of 1 insider transactions have happened at ChromaDex Corporation (CDXC) in the last six months, with sales accounting for 0 and purchases happening 1 times.

ChromaDex Corporation (CDXC): Who are the competitors?

The company’s main competitors (and peers) include Sangamo Therapeutics Inc. (SGMO) that is trading -6.52% down over the past 12 months. Exelixis Inc. (EXEL) is 13.94% up on the 1-year trading charts. Short interest in the company’s stock has fallen -11.71% from the last report on May 14, 2020 to stand at a total of 2.48 million short shares sold with a short interest ratio of 7.25.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free